Home/Pipeline/COVID‑19 Saliva Antigen Test

COVID‑19 Saliva Antigen Test

SARS‑CoV‑2 infection

Pre‑clinicalActive

Key Facts

Indication
SARS‑CoV‑2 infection
Phase
Pre‑clinical
Status
Active
Company

About Salignostics

Israeli startup delivering CE‑approved saliva‑based rapid tests for home and point‑of‑care diagnostics.

View full company profile

Other SARS‑CoV‑2 infection Drugs

DrugCompanyPhase
GammaFlu‑COVIDGamma VaccinesPreclinical